Skip to main content
. 2023 Dec 4;23:916. doi: 10.1186/s12909-023-04891-0

Table 4.

Clinician participation in MDT

Value N(%)
Whether participated in MDT
 Yes 425 (74)
 No 149 (26)
Main reasons for participating in MDT (multiple choices) (N = 425)
 Unclear diagnosis or difficulty in diagnosis and treatment in the department 353 (83.06)
 The diagnosis was clear, but the long-term treatment effect was poor 184 (43.29)
 The disease involved multi-organ and multi-system lesions requiring multi-department assistance 367 (86.35)
 The perioperative period is associated with multiple diseases and requires risk assessment 108 (25.41)
 Suspected acute infectious disease 8 (1.88)
 Emergency patients with difficult and critical cases cannot be diagnosed in time, affecting rescue 99 (23.29)
 Patients who are prone to medical disputes or certain key patients 156 (36.71)
The general duration of MDT (N = 425) (min)
 < 30 62 (14.58)
 30–60 307 (72.24)
 60–120 50 (11.76)
 > 120 6 (1.41)
Whether often followed up the prognosis of the patients after MDT
 Always 214 (50.35)
 Sometimes 188 (44.24)
 Never 23 (5.41)
Whether applied for MDT
 Yes 363 (63.2)
 No 211 (36.8)
Main reasons for applying for MDT (multiple choices) (N = 363)
 Unclear diagnosis or difficulty in diagnosis and treatment in the department 299 (82.37)
 Clear diagnosis with poor but long-term treatment effect 158 (43.53)
 The disease involved multi-organ and multi-system lesions requiring multi-department assistance 301 (82.92)
 The perioperative period is associated with multiple diseases and requires risk assessment 82 (22.59)
 Suspected acute infectious disease 9 (2.48)
 Emergency patients with difficult and critical cases cannot be diagnosed in time, affecting rescue 87 (23.97)
 Patients who are prone to medical disputes or certain key patients 153 (42.15)